TScan Therapeutics Announces Updates to its Board of Directors

Timothy Barberich retires as Chair; Stephen Biggar, M.D., Ph.D. assumes the role of Chair "We are pleased to welcome Garry to our Board of Directors. He has a breadth of experience in oncology development and commercialization spanning more than 35 years, including serving as president of Pfizer Oncology where he led its global oncology franchise," said Gavin MacBeath, Ph.D., Chief Executive Officer. "Garry has extensive expertise in operations, sales, regulatory strategy, and commercialization, and we look ...